Skip to main content

Table 3 Ethnic-specific prevalence ratios for cardiometabolic risk according to serum 25(OH)D status, NHANES 2001–2010

From: Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: a cross-sectional analysis of NHANES, 2001–2010

 

HOMAIR

  

MetS

  

CVD Risk (≥15%)

  
 

Yes

No

PR

95% CI

Yes

No

PR

95% CI

Yes

No

PR

95% CI

A

Mexican Americans

      

 25(OH)D quartiles (nmol/L)

            

   < 43.4

175

346

Ref

263

258

Ref

122

399

Ref

  43.4–58.6

156

445

0.9

0.70, 1.15

253

348

0.80 *

0.66, 0.97

132

469

0.85

0.66, 1.09

  58.7–74.2

94

366

0.82

0.63, 1.07

188

272

0.95

0.78, 1.16

109

351

0.87

0.67, 1.14

   ≥ 74.3

25

187

0.54 *

0.35, 0.82

67

145

0.73 *

0.55, 0.96

45

167

0.90

0.69, 1.16

Non-Hispanic Whites

            

 25(OH)D quartiles (nmol/L)

            

   < 43.4

178

274

Ref

255

197

Ref

156

296

Ref

  43.4–58.6

290

623

1.33

0.94, 1.36

452

461

1.07

0.95, 1.21

271

642

0.86

0.73, 1.01

  58.7–74.2

314

998

0.93

0.77, 1.24

565

747

1.00

0.88, 1.14

378

934

0.88

0.75, 1.04

   ≥ 74.3

290

1322

0.81 *

0.68, 0.96

528

1084

0.84 *

0.73, 0.95

364

1248

0.78 *

0.64, 0.93

Non-Hispanic Blacks

            

 25(OH)D quartiles (nmol/L)

            

   < 43.4

246

668

Ref

327

587

Ref

209

705

Ref

  43.4–58.6

80

300

0.89

0.71, 1.11

115

265

1.00

0.84, 1.19

92

288

0.83

0.65, 1.05

  58.7–74.2

53

147

1.03

0.78, 1.38

78

122

1.11

0.89, 1.37

66

134

0.98

0.78, 1.23

   ≥ 74.3

18

79

0.67 *

0.45, 0.99

34

63

0.74 *

0.56, 0.97

21

76

0.58 *

0.41, 0.81

B Excluding participants with self-reported diabetes, CVD, and those taking relevant medications

Mexican Americans

            

 25(OH)D quartiles (nmol/L)

            

   < 43.4

98

273

Ref

135

236

Ref

41

330

Ref

  43.4–58.6

89

343

0.99

0.72, 1.37

124

308

0.82

0.63, 1.07

32

400

0.49 *

0.29, 0.82

  58.7–74.2

56

289

0.98

0.69, 1.38

106

239

1.08

0.82, 1.41

37

308

0.81

0.46, 1.44

   ≥ 74.3

15

143

0.53 *

0.31, 0.91

31

127

0.63 *

0.44, 0.91

17

141

1.27

0.83, 1.94

Non-Hispanic Whites

            

 25(OH)D quartiles (nmol/L)

            

   < 43.4

86

166

Ref

98

154

Ref

46

206

Ref

  43.4–58.6

146

436

0.92

0.73, 1.19

184

398

0.98

0.79, 1.22

83

499

0.78

0.54, 1.13

  58.7–74.2

124

692

0.76 *

0.58, 0.99

198

618

0.89

0.71, 1.12

92

724

0.68 *

0.47, 0.97

   ≥ 74.3

105

931

0.61 *

0.44, 0.83

156

880

0.61 *

0.47, 0.80

96

940

0.56 *

0.39, 0.80

Non-Hispanic Blacks

            

 25(OH)D quartiles (nmol/L)

            

   < 43.4

126

488

Ref

128

486

Ref

63

551

Ref

  43.4–58.6

39

212

0.89

0.64, 1.24

42

209

1.05

0.77, 1.45

24

227

1.05

0.70, 1.58

  58.7–74.2

19

88

1.1

0.69, 1.76

26

81

1.49

1.06, 2.10

12

95

1.26

0.66, 2.38

   ≥ 74.3

5

54

0.73

0.32, 1.70

6

53

0.55

0.25, 1.21

6

53

0.72

0.33, 1.58

  1. Models are adjusted for age, sex, education, season of blood draw, survey cycle, smoking, BMI, total physical activity, vitamin D supplement use, and lipid and anti-hyperglycemic medications. * P < 0.05